Biotechnology SEZ – Advancing India’s Bio-Innovation Economy

Revolutionizing Biotechnology for a Healthier, Sustainable Future

Biotechnology SEZ

The Biotechnology SEZ at Quantum Semicon Smart City is India’s premier biotech innovation hub, modeled after Taiwan’s Hsinchu Biomedical Science Park and Singapore’s Biopolis. Designed to foster breakthroughs in biopharmaceuticals, genomics, synthetic biology, agricultural biotech, and medical research, this SEZ will drive self-reliance in critical healthcare technologies while making India a global leader in bio-exports.

By integrating R&D centers, high-tech bio-manufacturing facilities, clinical trial labs, and biotech startups, the park will accelerate drug discovery, vaccine development, and sustainable bioengineering—positioning India at the forefront of life sciences innovation.

Vision

To position India as a global leader in biotechnology, driving innovation in healthcare, agriculture, and bio-manufacturing while ensuring self-sufficiency in essential biologics and pharmaceuticals.

Mission

Develop cutting-edge biotech manufacturing infrastructure, including biopharma, biosimilars, and cell & gene therapy labs.
Attract global biotech giants like Moderna, Amgen, Genentech, Gilead, and Bayer to set up research & production centers.
Foster domestic biotech startups and enable rapid commercialization of indigenous bio-innovations.
Reduce dependence on imported biologics and pharmaceuticals by creating a fully integrated supply chain.
Build a robust biotech export ecosystem, positioning India as a global supplier of vaccines, monoclonal antibodies, and bio-agriculture solutions.

Strategic Importance of the Biotechnology SEZ

Advancing India’s Global Competitiveness in Biotechnology & Life Sciences

India’s biotech sector is valued at $80 billion, with the potential to reach $150 billion by 2025. However, heavy reliance on imported biologics, research bottlenecks, and fragmented infrastructure have limited India’s competitiveness.

The Biotechnology SEZ will solve these challenges by integrating world-class R&D, manufacturing, and regulatory compliance facilities, ensuring that India becomes a global hub for biotech innovation and exports.

State-of-the-Art Biotech Infrastructure

A High-Tech Ecosystem for Biopharmaceuticals & Synthetic Biology

This SEZ will host:

Biopharma Production Units for vaccines, biosimilars, monoclonal antibodies, and personalized medicine.
Advanced R&D Centers focused on genomics, stem cell research, CRISPR gene editing, and AI-powered drug discovery.
Good Manufacturing Practice (GMP) Labs for clinical trials, regulatory compliance, and bio-safety testing.
Synthetic Biology & Bioengineering Hubs for developing next-gen biofuels, biodegradable materials, and sustainable agriculture biotech solutions.

These facilities will enable India to compete with global biotech clusters like Boston’s Kendall Square and Switzerland’s Basel Biotech Hub.

Attracting Global Biotech & Pharma Giants

Building an Investment-Friendly Biotech Ecosystem

The Biotechnology SEZ will offer a regulatory-friendly and innovation-driven environment, attracting global pharmaceutical and life sciences leaders. By leveraging incentives, fast-track regulatory approvals, and tax benefits, this SEZ will become a preferred destination for multinational biotech firms and research collaborations.

Major global players such as Pfizer, Roche, Eli Lilly, and Novartis will be incentivized to set up R&D and production centers, ensuring technology transfer and global market integration.

Self-Reliance & Export Excellence

Strengthening India’s Position as a Global Biotech Export Hub

India currently imports over 60% of its biologics and advanced pharmaceuticals. The Biotechnology SEZ will reverse this dependency by enabling local production of high-value biologics, vaccines, and biosynthetic materials.

By streamlining biotech supply chains, this SEZ will allow India to export high-quality pharmaceuticals, gene therapies, and sustainable bio-products to the US, EU, and Asia. With a projected export revenue of $50 billion annually by 2035, this zone will be a key contributor to India’s biotech self-reliance and global leadership.

Driving Innovation in AI-Powered Drug Discovery & Genomics

Leveraging AI & Data Science for Faster Breakthroughs

AI and machine learning are revolutionizing drug discovery, precision medicine, and genomics. The Biotechnology SEZ will feature:

AI-Driven Drug Discovery Labs, partnering with global AI firms like NVIDIA & DeepMind.
Bioinformatics & Genomics Research Centers, accelerating personalized medicine and CRISPR-based therapies.
Big Data-Powered Clinical Trial Facilities, reducing drug development timelines and costs.

By integrating AI, computational biology, and quantum computing, this SEZ will place India at the forefront of next-gen biotech research.

Job Creation & Talent Development

Training India’s Next Generation of Biotech Innovators

The Biotechnology SEZ will create over 120,000 direct and indirect jobs, fostering expertise in biomanufacturing, genetic engineering, and bioinformatics.

This SEZ will:

Partner with IITs, AIIMS, and global biotech universities to train the next wave of biotech scientists & entrepreneurs.
Establish a Biotech Innovation Academy, offering specialized degrees and certifications in synthetic biology, AI-driven drug discovery, and regenerative medicine.
Provide hands-on training in GMP-compliant biomanufacturing and clinical research methodologies.

By bridging the biotech skills gap, this zone will ensure India remains competitive in life sciences innovation.

Sustainability & Green Biotech Manufacturing

Creating a Low-Carbon, Eco-Friendly Biotech Industry

Biotechnology plays a crucial role in sustainability and environmental conservation. The SEZ will focus on:

Bio-based alternatives to plastics, chemicals, and fossil fuels.
Zero-waste and closed-loop manufacturing for biotech processes.
AI-optimized energy use in biopharma production to reduce emissions and improve efficiency.

By integrating green biomanufacturing practices, this SEZ will align with India’s commitment to climate-friendly industrialization.

Why Invest in the Biotechnology SEZ?

Strategic Location: Close to major research universities, industrial hubs, and global pharma supply chains.
State-of-the-Art Facilities: AI-driven R&D labs, GMP-certified manufacturing units, and bioengineering hubs.
Government Incentives: PLI schemes, biotech R&D grants, and streamlined regulatory approvals.
Highly Skilled Workforce: Access to India’s top biotech researchers, data scientists, and medical professionals.
Global Market Reach: Export-focused SEZ, positioned as a biotech powerhouse for Asia and beyond.

Be Part of India’s Biotech Revolution

Join the Future of Life Sciences at the Biotechnology SEZ

The Biotechnology SEZ at Quantum Semicon Smart City is India’s gateway to biotech leadership. Whether you’re a global pharmaceutical company, biotech startup, or venture capitalist, this SEZ offers world-class infrastructure, cutting-edge research facilities, and industry-leading incentives.

Contact us today to explore investment opportunities and help shape the future of India’s biotech success!

Tailored Solutions for Modern Urban Challenges

Strategic Importance of the Integrated Circuits SEZ

Strengthening India’s Semiconductor Industry for Domestic & Global Markets
The Integrated Circuits SEZ will not only catalyze India's digital economy but also create a sustainable and globally competitive semiconductor industry. With a focus on both export-led growth and domestic supply security, this SEZ will integrate India into global semiconductor supply chains while ensuring that the country has access to critical technologies required for industrial and consumer applications.